Related Experiment Video
Updated: May 8, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Anti-interleukin-5 therapy in severe asthma
Gilles Garcia1, Camille Taillé, Pierantonio Laveneziana
1Faculté de médecine, Université Paris-Sud, Le Kremlin-Bicêtre, France. gilles.garcia@bct.aphp.fr
Summary
Severe asthma treatment is advancing with new options targeting interleukin-5 (IL-5). These therapies focus on reducing eosinophils, key players in airway inflammation, offering hope for patients with difficult-to-manage asthma.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma is a chronic airway inflammatory disease with severe cases presenting persistent symptoms despite high-dose treatments.
- Eosinophils play a critical role in asthma pathogenesis, causing airway damage through various mechanisms.
- Interleukin-5 (IL-5) is a key regulator of eosinophil activity, including their recruitment, activation, and survival.
Purpose of the Study:
- To review novel therapeutic strategies for severe asthma.
- To focus on treatments targeting the interleukin-5 (IL-5) pathway.
- To evaluate clinical trial data for IL-5-targeted therapies in asthmatic patients.
Main Methods:
- Review of existing scientific literature and clinical trial data.
- Focus on pharmacological interventions targeting specific cytokines, particularly IL-5.
- Analysis of monoclonal antibodies designed to interfere with IL-5 signaling.
Main Results:
- IL-5 inhibition has demonstrated efficacy in treating asthma, especially severe forms.
- Targeting eosinophil function or numbers via IL-5 blockade is a significant therapeutic goal.
- Clinical trials have evaluated the effectiveness of IL-5-targeted monoclonal antibodies.
Conclusions:
- New treatment options for severe asthma are emerging, particularly those focused on the IL-5 pathway.
- Interfering with IL-5 offers a promising approach to manage eosinophilic airway inflammation in severe asthma.
- Further evaluation of IL-5-targeted therapies is crucial for improving outcomes in severe asthma patients.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...